Tirzepatide 40mg | 3ml Vial | Research Peptide

Tirzepatide 40mg is a next-generation research peptide that acts as a dual agonist on GIP and GLP-1 receptors, making it one of the most advanced compounds currently being studied in metabolic research.

This higher-dose 40mg vial is ideal for researchers looking for extended study duration or higher concentration protocols.

Key Research Areas

• Appetite regulation and satiety signaling
• Glucose metabolism and insulin sensitivity
• Energy expenditure and metabolic efficiency
• Weight management pathways

Tirzepatide’s dual receptor mechanism sets it apart from traditional single-pathway peptides, making it a powerful subject in ongoing metabolic and endocrine research.

Product Specifications

• Compound: Tirzepatide
• Dosage: 40mg
• Vial Size: 3ml
• Form: Lyophilized powder
• Purity: High purity (third-party tested depending on supplier)
• Storage: Store in a cool, dry place before reconstitution

What Makes This Different

Unlike traditional GLP-only compounds, Tirzepatide activates both:

• GLP-1 receptors (appetite & insulin response)
• GIP receptors (enhanced metabolic signaling)

This dual-action profile is why it has become one of the most researched peptides currently available.

Reconstitution 

• Typically reconstituted with bacteriostatic water
• Common approach: 3ml BAC water for full vial
• Adjust based on research needs and protocol

Disclaimer

For research use only.